午盤收盤，國內期貨主力合約跌多漲少，低硫燃料油（LU）跌超6%，燃料油跌超5%，碳酸鋰跌近4%，苯乙烯（EB）、純苯、棕櫚油、瀝青、滬錫跌近3%。漲幅方面，鈀漲超4%，滬銀、燒鹼漲超3%，滬金、多晶硅漲超2%，純鹼漲近2%，玻璃、紙漿漲超1%。

The National Health Commission and the National Administration of Traditional Chinese Medicine have revised the 2018 Procedures for Drafting the Rare Disease Catalogue and issued a 2026 edition to strengthen rare-disease management and improve the catalogue's scientific basis while enhancing diagnosis, treatment and patient support. Major changes: expanded criteria for inclusion and broader disease coverage; additional eligible applicants for proposing catalogue entries to involve relevant professional bodies; the National Administration of Traditional Chinese Medicine added as a co-issuing agency, with clarified TCM responsibilities and an emphasis on TCM–Western medicine coordination in rare-disease prevention and treatment; optimization of the drafting cycle to enable timely updates in practice; and explicit guidance that the catalogue is for reference use by relevant departments.

Shanghai and Shenzhen equity turnover totaled RMB 2.038 trillion on Nov 4, up RMB 334.3 bln from the prior session. Shanghai turnover was RMB 953.3 bln (prev. RMB 810.8 bln), traded volume 599 mln lots (prev. 537 mln). Shenzhen turnover was RMB 1,084.4 bln (prev. RMB 892.6 bln), traded volume 682 mln lots (prev. 579 mln). Top by turnover: Zhongji Xuchuang RMB 30.7 bln, Xinyisheng RMB 21.0 bln, Changxin Technology RMB 21.0 bln, Dongshan Precision RMB 17.7 bln, CATL RMB 14.1 bln.